IL-17 and limits of success.

Omidian, Zahra; Ahmed, Rizwan; Giwa, Adebola; Donner, Thomas; Hamad, Abdel Rahim A

Omidian, Zahra; Ahmed, Rizwan; Giwa, Adebola; Donner, Thomas; Hamad, Abdel Rahim A.

Afiliación

Omidian Z; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States.
Ahmed R; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States.
Giwa A; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States.
Donner T; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States.
Hamad ARA; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States. Electronic address: ahamad@jhmi.edu.

Cell Immunol ; 339: 33-40, 2019 05.

Article en En | MEDLINE | ID: mdl-30765202

Asunto(s)

Interleucina-17/inmunología; Animales; Enfermedades Autoinmunes/inmunología; Humanos; Inmunoterapia/métodos; Enfermedades Inflamatorias del Intestino/inmunología; Esclerosis Múltiple/inmunología

Palabras clave

Autoimmune diseases; Clinical trials; IL-17; Immunotherapy; Interleukin-17

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-17 Límite: Animals / Humans Idioma: En Revista: Cell Immunol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google